A Clinical and Biological Comparison Between Malignant Mixed Müllerian Tumors and Grade 3 Endometrioid Endometrial Carcinomas
Authors:
- Rebecca StoneRSRebecca Stone
- Cara HeuserCHCara Heuser
- Jianfen ShuJSJianfen Shu
- Amir JazaeriAJAmir Jazaeri
- Jamie ShutterJSJamie Shutter
- Kristin AtkinsKAKristin Atkins
- Laurel RiceLRLaurel Rice
- 1 January 2009
- journal article
- research article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 19 (2) , 261-265
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Combined adjuvant cisplatin and ifosfamide chemotherapy and radiotherapy for malignant mixed mullerian tumors of the uterusInternational Journal of Gynecological Cancer, 2006
- Biologic targets for therapeutic intervention in endometrioid endometrial adenocarcinoma and malignant mixed müllerian tumorsAmerican Journal of Obstetrics and Gynecology, 2006
- Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometriumGynecologic Oncology, 2004
- Phase III Trial of Doxorubicin With or Without Cisplatin in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2004
- Malignant mixed müllerian tumors of the uterus: Analysis of patterns of failure, prognostic factors, and treatment outcomeInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomasInternational Journal of Gynecological Cancer, 2002
- Insulin Receptor Substrate-1 is the Predominant Signaling Molecule Activated by Insulin-like Growth Factor-I, Insulin, and Interleukin-4 in Estrogen Receptor-positive Human Breast Cancer CellsJournal of Biological Chemistry, 1998
- Immunohistochemically detected HER-2/neu-expression and prognosis in endometrial carcinomaArchives of Gynecology and Obstetrics, 1997
- Primary treatment of endometrial carcinoma with high-dose-rate brachytherapy: Results of 12 years of experience with 280 patientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1997
- Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1986